112957 ⎘
Oligonucleotides characterized by their use Haplotypes
METHODS AND COMPOSITIONS FOR ASSESSMENT OF PULMONARY FUNCTION AND DISORDERS
#602METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE SULT4A1-1 HAPLOTYPE
#603BIOMARKER FOR SUCCESSFUL AGING WITHOUT COGNITIVE DECLINE
#604GENETIC POLYMORPHISMS ASSOCIATED WITH LIVER FIBROSIS METHODS OF DETECTION AND USES THEREOF
#605DIAGNOSIS MARKER, DIAGNOSIS METHOD AND THERAPEUTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS, AND ANIMAL MODEL AND CELL MODEL DEVELOPING AMYOTROPHIC LATERAL SCLEROSIS
#606Method to identify disease resistant quantitative trait loci in soybean and compositions thereof
#607GENE CONTROLLING CHASMOGAMY/CLEISTOGAMY OF PLANT AND USE THEREOF
#608GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS, METHODS OF DETECTION AND USES THEREOF
#609GENETIC VARIANTS INDICATIVE OF VASCULAR CONDITIONS
#610Targets for use in diagnosis, prognosis and therapy of cancer
#611Oligonucleotide array for tissue typing
#612Methods of detecting Charcot-Marie Tooth disease type 2A
#613CC2D2A gene mutations associated with joubert syndrome and diagnostic methods for identifying the same
#614Detection of mutations in a gene associated with resistance to viral infection, OAS1
#615ACE2 activation for treatment of heart, lung and kidney disease and hypertension
#616Susceptibility Genes for Age-Related Maculopathy (ARM) on Chromosome 10q26
#617METHOD FOR DETERMINING THE RISK OF OCCURRENCE OF ALZHEIMER'S DISEASE
#618METHODS AND MATERIALS FOR ASSESSING THE CIS/TRANS NATURE OF HUMANS HAVING CYP2C19*2 AND CYP2C19*17 ALLELES
#619COMPOSITIONS AND METHODS FOR ASSESSING A GENETIC RISK OF DEVELOPING LATE-ONSET ALZHEIMER'S DISEASE (LOAD)
#620Hair shape susceptibility gene
#621METHOD FOR NON-INVASIVE PRENATAL DIAGNOSIS
#622sPLA2 IIA Polymorphism Analysis for the Diagnosis/Prognosis of a Cardiovascular Disease/Event
#623NUTRIGENETIC BIOMARKERS FOR OBESITY AND TYPE 2 DIABETES
#624Genetic markers associated with risk of diabetes mellitus
#625TREATMENT WITH CYTOKINES
#626DISEASE-ASSOCIATED GENETIC VARIATIONS AND METHODS FOR OBTAINING AND USING SAME
#627SIRTUIN 5 POLYMORPHISMS AND NEUROLOGICAL DISEASES
#628GENETIC SUSCEPTIBILITY VARIANTS ASSOCIATED WITH CARDIOVASCULAR DISEASE
#629Disease susceptibility
#630Method and Kit for Determining Severity and Progression of Periodontal Disease
#631METHOD FOR DETERMINING THE RISK OF DEVELOPING A NEUROLOGICAL DISEASE
#632GENETIC TEST FOR LIVER COPPER ACCUMULATION IN DOGS AND LOW COPPER PET DIET
#633METHODS RELATED TO A MUTATION IN COMPLEMENT FACTOR H-RELATED PROTEIN 5 IN PATIENTS WITH GLOMERULONEPHRITIS
#634Diagnostic methods
#635Non-invasive determination of fetal inheritance of parental haplotypes at the genome-wide scale
#636METHOD AND APPARATUS FOR DIAGNOSING AGE-RELATED MACULAR DEGENERATION
#637RESISTANCE GENES AND PROTEINS ACTIVE AGAINST FUSARIUM ROOT ROTS, CYST NEMATODES AND SOYBEAN SUDDEN DEATH SYNDROME AND METHODS EMPLOYING SAME
#638METHODS FOR SELECTING THERAPIES TO IMPROVE HDL CHOLESTEROL AND TRIGLYCERIDE LEVELS
#639Detecting genetic abnormalities
#640GENETIC MARKERS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION, METHODS OF DETECTION AND USES THEREOF
#641Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs
#642Brassica plants resistant to disease
#643Methods and drug products for treating Alzheimer's disease
#644Method of Determining Response to Treatment with Immunomodulatory Composition
#645Methods for diagnosing and treating eye-length related disorders
#646Genetic variant of the annexin A5 gene
#647GENETIC POLYMORPHISMS ASSOCIATED WITH ADVANCED LUNG DISEASES
#648CHK2 polymorphism as a cancer marker
#649METHODS AND COMPOSITIONS FOR ASSESSMENT OF PULMONARY FUNCTION AND DISORDERS
#650METHODS AND COMPOSITIONS FOR CORRELATING GENETIC MARKERS WITH SUDDEN CARDIAC DEATH RISK
#651SUSCEPTIBILITY TO BONE DAMAGE
#652Method for HLA typing
#653SINGLE NUCLEOTIDE POLYMORPHISMS IN BRCA1 AND CANCER RISK
#654Genetic Variants in the TCF7L2 Gene as Diagnostic Markers for Risk of Type 2 Diabetes Mellitus
#655Diagnostic Markers for Ankylosing Spondylitis
#656METHODS OF SELECTION, REPORTING AND ANALYSIS OF GENETIC MARKERS USING BROAD-BASED GENETIC PROFILING APPLICATIONS
#657PROGNOSTIC MARKER FOR MAMMA CARCINOMA
#658RCA LOCUS ANALYSIS TO ASSESS SUSCEPTIBILITY TO AMD AND MPGNII
#659COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MACULAR DEGENERATION
#660Fibrosis susceptibility gene and uses thereof
#661GENE SEQUENCE VARIANCES IN GENES RELATED TO FOLATE METABOLISM HAVING UTILITY IN DETERMINING THE TREATMENT OF DISEASE
#662METHODS AND COMPOSITIONS FOR TREATING OCULAR DISORDERS
#663GENES LINKING SEVERAL COMPLICATIONS OF TYPE-2 DIABETES (T2D)
#664BRM Expression and Related Diagnostics
#665Genetic Variants Predictive of Cancer Risk in Humans
#666Gene Marker For Evaluating Genetic Potential For Marbling In Bovine Individual And Method For Evaluating Genetic Potential For Marbling Using The Same
#667Predicting And Treating Prostate Cancer
#668Plant resistant to a pathogen
#669Allelic Variants Associated with Advanced Age-Related Macular Degeneration
#670Methods of Predicting Osteoarthritis
#671GENETIC LESION ASSOCIATED WITH CANCER
#672Method for Diagnosing or Predicting a Non Syndromic Autosomal Recessive Optic Atrophy, or a Risk of a Non Syndromic Autosomal Recessive Optic Atrophy
#673COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS
#674Method for determining the predisposition of a patient to changed biotransformation and to the development of undesired drug effects in a treatment of the patient with atrovastatin
#675ESTROGEN RECEPTOR ALLELES THAT ARE PREDICTIVE OF INCREASED SUSCEPTIBILITY TO BONE FRACTURE
#676Compositions and polyeptides related to type 1 diacylgycerol O-acyltransferase (DGAT)
#677METHOD FOR DETERMINING RISK FOR KIDNEY STONES DEVELOPING OR RECURRING AND METHOD FOR USING SINGLE-NUCLEOTIDE POLYMORPHISM RS12313273 AS BIOMARKER FOR DETERMINING DEVELOPMENT OR RECURRENCE OF KIDNEY STONE
#678GENETIC VARIANTS IN ANGIOGENESIS PATHWAY ASSOCIATED WITH CLINICAL OUTCOME
#679MEANS AND METHODS FOR DIAGNOSING PREDISPOSITION FOR TREATMENT EMERGENT SUICIDAL IDEATION (TESI)
#680Forensic identification
#681Compositions, methods, and systems for inferring bovine breed
#682METHODS OF DIAGNOSING INSULIN RESISTANCE AND SENSITIVITY
#683GENETIC POLYMORPHISMS ASSOCIATED WITH PSORIASIS, METHODS OF DETECTION AND USES THEREOF
#684Apparatus and methods for parallel processing of micro-volume liquid reactions
#685Variants in complement regulatory genes predict age-related macular degeneration
#686Lafora's disease gene
#687Genotyping tool for improving the prognostic and clinical management of MS patients
#688METHOD OF DETERMINING A PREDISPOSITION TO ATRIAL FIBRILLATION (AF) IN A SUBJECT
#689Methods of diagnosing hypophosphatemic disorders
#690GENETIC POLYMORPHISMS ASSOCIATED WITH LIVER FIBROSIS, METHODS OF DETECTION AND USES THEREOF
#691Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
#692Corn variety DE811ASR(BC5)
#693METHOD FOR IMPROVING BIOMASS YIELD
#694FUS/TLS-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases
#695COMPOSITIONS AND METHODS FOR DIAGNOSING AND PREVENTING SPONTANEOUS PRETERM BIRTH
#696METHODS OF USING SMAD3 AND JAK2 GENETIC VARIANTS TO DIAGNOSE AND PREDICT INFLAMMATORY BOWEL DISEASE
#697Methods and Reagents for Treatment and Diagnosis of Vascular Disorders and Age-Related Macular Degeneration
#698COMPOSITIONS, METHODS AND KITS TO DETECT DICER GENE MUTATIONS
#699COMPOSITIONS, METHODS AND KITS TO DETECT DICER GENE MUTATIONS
#700Genetic markers of schizophrenia
#701Genetic markers of schizophrenia
#702Polymorphism in CYP3A4 gene affecting drug metabolizing and uses thereof
#703GENETIC TEST FOR LIVER COPPER ACCUMULATION IN DOGS AND LOW COPPER PET DIET
#704Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
#705LRRK2 polynucleotides
#706METHOD FOR DETERMINING A RISK, FOR A SUBJECT, OF SUFFERING FROM ATOPIC DERMATITIS OR SEVERITY OF ATOPIC DERMATITIS FOR A SUBJECT SUFFERING FROM ATOPIC DERMATITIS AND METHOD FOR USING A SINGLE-NUCLEOTIDE POLYMORPHISM RS12313273 AS A BIOMARKER FOR DETERMINING THE DEVELOPMENT OR SEVERITY OF ATOPIC DERMATITIS
#707METHOD FOR PROVIDING INFORMATION ON ANTIDEPRESSANT THERAPEUTIC EFFECT USING SINGLE NUCLEOTIDE POLYMORPHISM
#708SNP Marker of Breast and Ovarian Cancer Risk
#709METHOD AND COMPOSITIONS FOR CANCER PROGNOSIS
#710Genetic markers for risk management of atrial fibrillation and stroke
#711RADIATION THERAPY BIOMARKERS
#712PREDICTION OF LIPID-METABOTYPE-RELATED PHYSIOLOGICAL SUSCEPTIBILITIES
#713METHODS AND KITS FOR DETERMINING PREDISPOSITION TO CANCER
#714GENETIC POLYMORPHISMS ASSOCIATED WITH PSORIASIS, METHODS OF DETECTION AND USES THEREOF
#715ENPP1 (PC-1) GENE HAPLOTYPE ASSOCIATED WITH THE RISK OF OBESITY AND TYPE 2 DIABETES AND THEIR APPLICATIONS
#716DOPAMINE-BETA-HYDROXYLASE GENETIC POLYMORPHISM AND MIGRAINE
#717METHODS FOR ASSESSING RISK OF ALZHEIMER'S DISEASE IN A PATIENT
#718GENETIC POLYMORPHISMS IN THE PROSTATE-SPECIFIC ANTIGEN GENE PROMOTER
#719METHODS AND KITS FOR DETERMINING PREDISPOSITION TO DEVELOP KIDNEY DISEASES
#720OLIGONUCLEOTIDES AND METHODS FOR DETERMINING SUSCEPTIBILITY TO SOFT TISSUE INJURIES
#721METHODS FOR APCDD1 MEDIATED REGULATION OF HAIR GROWTH AND PIGMENTATION AND MUTANTS THEREOF
#722GENETIC SEVERITY MARKERS IN MULTIPLE SCLEROSIS
#723BANK1 RELATED SNPS AND SLE AND/OR MS SUSCEPTIBILITY
#724METHOD FOR DETERMINING THE PREDISPOSITION FOR CROHN'S DISEASE
#725DPYD GENE VARIANTS AND USE THEREOF
#726Single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the IGF2 gene
#727Method for Confirming a Diagnosis of Rolandic Epilepsy
#728Methods for Healthy Aging
#729Polynucleotides Associated With Age-Related Macular Degeneration and Methods for Evaluating Patient Risks
#730METHODS FOR BREAST CANCER RISK ASSESSMENT
#731Genetic variants for breast cancer risk assessment
#732Methods for detecting neovascular age-related macular degeneration
#733GENETIC POLYMORPHISMS ASSOCIATED WITH RHEUMATOID ARTHRITIS, METHODS OF DETECTION AND USES THEREOF
#734Methods for non-invasive prenatal ploidy calling
#735Genetic Variants Useful for Risk Assessment of Thyroid Cancer
#736Compositions and methods for diagnosis and treatment of epilepsy
#737GENETIC LOCI ASSOCIATED WITH CELL WALL DIGESTIBILITY IN MAIZE
#738Identifying High Risk Clinically Isolated Syndrome Patients
#739Method for diagnosing and predicting cerebellar ataxia
#740Ribonucleic acid binding motif protein 20 sequence variants
#741Ets-2 Biomarkers for Fibrotic Diseases and Uses Thereof
#742Size-based genomic analysis
#743Method to identify disease resistant quantitative trait loci in soybean and compositions thereof
#744GENETIC POLYMORPHISMS ASSOCIATED WITH STATIN RESPONSE AND CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF
#745Genetic Variants as Markers for Use in Urinary Bladder Cancer Risk Assessment, Diagnosis, Prognosis and Treatment
#746FORENSIC IDENTIFICATION
#747METHODS AND COMPOSITIONS FOR PREDICTING DEVELOPMENT OF ATOPIC DISEASES
#748Identification of mutation and method for detecting lavender foal syndrome in the horse
#749Markers associated with Alzheimer'S disease
#750Analysis of Y-Chromosome STR Markers
#751Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm
#752POLYMORPHISM MARKERS FOR PREDICTING RESPONSE TO INTERLEUKIN-6 RECEPTOR-INHIBITING MONOCLONAL ANTIBODY DRUG TREATMENT
#753COMPOSITIONS AND METHODS FOR TREATING GROWTH HORMONE DEFICIENCY
#754Methods of producing maize plants having a high oil phenotype by detecting a marker locus genetically linked with a QTL6 region
#755ADRB2 GENE POLYMORPHISM ASSOCIATED WITH INTRAOCULAR PRESSURE RESPONSE TO TOPICAL BETA-BLOCKERS
#756Digital analyte analysis
#757NOVEL ALLELIC VARIANT OF CYP2C19 ASSOCIATED WITH DRUG METABOLISM
#758FAST ASSIGNMENT OF ADEQUATE CHEMOTHERAPY WITH LATINUM BASED DRUGS FOR CANCER PATIENTS BASED ON THE IDENTIFICATION OF CONSTITUTIONAL BRCAL MUTATIONS
#759Digital analyte analysis
#760Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1
#761BIOMARKERS FOR DRUG-INDUCED ELONGATED QT INTERVAL AND TORSADES DE POINTES
#762RGS2 genotypes associated with extrapyramidal symptoms induced by antipsychotic medication
#763Genetic Variants Predicting Warfarin Sensitivity
#764METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING A COLORECTAL ADENOCARCINOMA
#765Genetic Alterations on Chromosomes 21q, 6q and 15q and Methods of Use Thereof for the Diagnosis and Treatment of Type I Diabetes
#766Genetic Variants Useful for Risk Assessment of Thyroid Cancer
#767Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing
#768Methods for identifying the habitats of insects
#769METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNF ALPHA THERAPY IN INFLAMMATORY BOWEL DISEASE
#770METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASE SECONDARY TO MULTIPLE SCLEROSIS
#771SINGLE NUCLEOTIDE POLYMORPHIC MARKERS OF TGFBetaRIII GENE FOR DIAGONISIS OF HEPATOCELLULAR CARCINOMA
#772Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides
#773Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders
#774Methods for the early diagnosis of ovarian cancer
#775Genetic Variants Predictive of Cancer Risk
#776BIOMARKERS FOR PREDICTING THE DEVELOPMENT OF CHRONIC AUTOIMMUNE DISEASES
#777Method of Using FOXO3A Polymorphisms and Haplotypes to Predict and Promote Healthy Aging and Longevity
#778Methods and systems for inferring bovine traits
#779HLA alleles associated with adverse drug reactions and methods for detecting such
#780Methods and Compositions for Treating Neuroblastoma
#781POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSALICYLIC ACID TREATMENT
#782Method for Diagnosing a Genetic Predisposition for Vascular Disease
#783DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE (AD)
#784METHODS AND COMPOSITIONS FOR DETECTING RECESSIVE FAMILIAL FSGS AND USES THEREOF
#785Methods and compositions for genetically detecting improved milk production traits in cattle
#786Method and Markers for Determining the Genotype of Horned/Polled Cattle
#787Genetic markers associated with drought tolerance in maize
#788Method For Administering Anticoagulation Therapy
#789Diagnostic methods involving determining gene copy numbers and SNPS in the FcγRII/FcγRIII gene cluster, and probes for use in such methods to detect susceptibility to and treatment efficacy in autoimmune diseases
#790ASSESSMENT OF RISK FOR COLORECTAL CANCER
#791Method of identifying disease risk factors
#792NUTRIGENOMICS METHODS AND COMPOSITIONS
#793Genetic LOCI on maize chromosomes 3 and 4 that are associated with fusarium ear mold resistance
#794HPPD-inhibitor herbicide tolerance
#795Polynucleotide and polypeptide sequences associated with herbicide tolerance
#796METHODS AND COMPOSITIONS FOR ASSESSMENT OF PULMONARY FUNCTION AND DISORDERS
#797METHODS OF ANALYSIS OF POLYMORPHISMS AND USES THEREOF
#798Variation in the CHI3L1 Gene Influences Serum YKL-40 Levels, Asthma Risk and Lung Function
#799METHODS AND MATERIALS FOR IDENTIFYING POLYMORPHIC VARIANTS, DIAGNOSING SUSCEPTIBILITIES, AND TREATING DISEASE
#800Polymorphisms Associated With Age-Related Macular Degeneration And Methods For Evaluating Patient Risk
#801CARDIAC RISK STRATIFICATION BY NOS1AP GENOTYPING
#802IDENTIFICATION OF PEDIATRIC ONSET INFLAMMATORY DISEASE LOCI AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME
#803PREDICTING AND REDUCING ALLOIMMUNOGENICITY OF PROTEIN THERAPEUTICS
#804Molecular structure of RHD negative
#805Methods for identifying an individual at increased risk of developing coronary artery disease
#806PROTEIN C RS2069915 AS A RESPONSE PREDICTOR TO SURVIVAL AND ADMINISTRATION OF ACTIVATED PROTEIN C OR PROTEIN C-LIKE COMPOUND
#807METHODS AND KITS FOR DETECTING RISK FACTORS FOR DEVELOPMENT OF JAW OSTEONECROSIS AND METHODS OF TREATMENT THEREOF
#808METHODS FOR DIAGNOSING OR PREDICTING HEPATITIS C OUTCOME IN HCV INFECTED PATIENTS
#809Sorghum fertility restorer genotypes and methods of marker-assisted selection
#810Thymidylate Synthase Haplotype is Associated with Tumor Recurrence in Stage II and Stage III Colon Cancer Patients
#811GENETIC COMPONENT OF COMPLICATIONS IN TYPE 2 DIABETES
#812TEST METHOD FOR TYPE-2 DIABETES USING GENE POLYMORPHISM
#813Compositions and Methods for Increasing Bone Mineralization
#814Marker mapping and resistance gene associations in soybean
#815plant comprising mutant fatty acyl-ACP thioesterase alleles
#816Microsatellite Markers of Schizophrenia
#817ROLES FOR DUAL ENDOTHELIN-1/ANGIOTENSIN II RECEPTOR (DEAR) IN HYPERTENSION AND ANGIOGENESIS
#818COMPOSITIONS AND METHODS FOR DIAGNOSING LATE-ONSET ALZHEIMER'S DISEASE
#819Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
#820Determination of KIR haplotypes associated with disease
#821METHOD FOR DETERMINATION OF INFLAMMATORY DISEASE BY USING SINGLE NUCLEOTIDE POLYMORPHISM IN BRCA1-RELATED PROTEIN (BRAP) GENE
#822HUMAN DIABETES SUSCEPTIBILITY TNFRSF10B GENE
#823DIAGNOSIS OF HEREDITARY SPASTIC PARAPLEGIAS (HSP) BY INDENTIFICATION OF A MUTATION IN THE KIAA1840 GENE OR PROTEIN
#824Methods and compositions for identifying downy mildew resistant cucumber plants
#825Diagnostic and therapeutic methods for EFMR (epilepsy and mental retardation limited to females)
#826METHODS OF DIAGNOSING AND CHARACTERIZING CANNABINOID SIGNALING IN CROHN'S DISEASE
#827Methods and compositions for vitamin K epoxide reductase
#828Method of screening compounds using CALHM (FAM26C)
#829Methods of Using Genetic Markers and Related Epistatic Interactions
#830FTO GENE POLYMORPHISMS ASSOCIATED TO OBESITY AND/OR TYPE II DIABETES
#831Methods and Compositions For Diagnosis of Age-Related Macular Degeneration
#832METHODS OF USING A NOD2/CARD15 HAPLOTYPE TO DIAGNOSE CROHN'S DISEASE
#833Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms
#834GENETIC VARIANTS ON CHR2 AND CHR16 AS MARKERS FOR USE IN BREAST CANCER RISK ASSESSMENT, DIAGNOSIS, PROGNOSIS AND TREATMENT
#835Microsatellite Markers of Schizophrenia
#836SIRT1 POLYMORPHIC VARIANTS AND METHODS OF USE THEREOF
#837DIAGNOSTIC METHODS
#838USE OF GLIS3 FOR PREPARING FUNCTIONAL PANCREATIC BETA-CELLS
#839Copy Number Variations Predictive of Risk of Schizophrenia
#840USE OF IRON-RELATED PATHWAYS AND GENES FOR TREATMENT AND DIAGNOSIS OF PARKINSON'S DISEASE
#841Novel genes and markers in type 2 diabetes and obesity
#842Novel genes and markers in type 2 diabetes and obesity
#843Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) Polymorphisms As Indicators of Subject Outcome in Critically Ill Subjects
#844Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
#845Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
#846Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
#847Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
#848METHOD FOR DETERMINING REDUCED PREDISPOSITION TO CANCER BASED ON GENETIC PROFILE
#849ANDROGENETIC ALOPECIA
#850Single nucleotide polymorphisms and the identification of lactose intolerance
#851Methods and Compositions for the Diagnosis and Treatment of Angiogenic Disorders
#852SNP DETECTION AND OTHER METHODS FOR CHARACTERIZING AND TREATING BIPOLAR DISORDER AND OTHER AILMENTS
#853METHOD TO PREDICT IRIS COLOR
#854MUTANT SODIUM CHANNEL NAV 1.7 AND METHODS RELATED THERETO
#855POLYMORPHISMS PREDICTIVE OF PLATINUM-COORDINATING COMPOUND-INDUCED OTOTOXICITY
#856Physiogenomic method for predicting drug metabolism reserve for antidepressants and stimulants
#857Method of judging inflammatory disease by using single nucleotide polymorphism
#858plants with increased fiber strength comprising a fiber strength allele spanning the GLUC1.1A gene from
#859Susceptibility variants for lung cancer
#860DAIRY CATTLE BREEDING FOR IMPROVED MILK PRODUCTION TRAITS IN CATTLE
#861IN VITRO METHOD FOR DIAGNOSING SKIN CANCER
#862METHODS FOR PREDICTING THE DEVELOPMENT AND RESOLUTION OF ACUTE RESPIRATORY DISTRESS SYNDROME
#863Haplotype tagging single nucleotide polymorphisms and use of same to predict childhood lymphoblastic leukemia
#864GENE AND PATHWAY AND THEIR USE IN METHODS AND COMPOSITIONS FOR PREDICTING ONSET OR PROGRESSION OF AUTOIMMUNE AND/OR AUTOINFLAMMATORY DISEASES
#865Cystic fibrosis transmembrane conductance regulator gene mutations
#866Detection of mutations in a gene associated with resistance to viral infection, OAS1
#867Lsamp gene associated with cardiovascular disease
#868OSTEOARTHRITIS-SENSITIVE GENE
#869Methods for the assessment of drug response
#870Kruppel-like factor 6 (KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein
#871Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms
#872DOMINANT EARLINESS MUTATION AND GENE IN SUNFLOWER (HELIANTHUS ANNUUS)
#873Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
#874GENETIC MARKERS FOR ASSESSING RISK OF PREMATURE BIRTH RESULTING FROM PRETERM PREMATURE RUPTURE MEMBRANES
#875Diagnosis and Treatment of Age Related Macular Degeneration
#876METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING LUPUS
#877METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE
#878Method of identifying maize plants having increased oil content using quantitative trait locus 6 (QTL6)
#879Single nucleotide polymorphisms (SNPs) in genes associated with inflammatory diseases
#880SUSCEPTIBILITY TO BONE DAMAGE
#881POLYMORPHISMS IN THE FCGR2B PROMOTER AND USES THEREOF
#882METHOD AND TESTING A SUBJECT THOUGHT TO BE PREDISPOSED TO LUNG CANCER
#883DIAGNOSTIC MARKER AND PLATFORM FOR DRUG DESIGN IN MYOCARDIAL INFARCTION AND HEART FAILURE
#884Genetic polymorphisms and infertility
#885METHODS FOR CELL GENOTYPING
#886OVINE IDENTIFICATION METHOD
#887Genetic variants in a hypertension susceptibility gene Stk39 and uses thereof
#888DETECTION OF MUTATIONS IN ACTA2 AND MYH11 FOR ASSESSING RISK OF VASCULAR DISEASE
#889HUMAN DIABETES SUSCEPTIBILITY EEFSEC GENE
#890PROTEIN C PATHWAY ASSOCIATED POLYMORPHISMS AS RESPONSE PREDICTORS TO ACTIVATED PROTEIN C OR PROTEIN C-LIKE COMPOUND ADMINISTRATION
#891PREDICTIVE TEST FOR ADULT DOG BODY SIZE
#892Nucleic acids, methods and kits for the diagnosis of DYT6 primary torsion dystonia
#893Methods and Compositions for Identifying, Diagnosing, and Treating Neuroblastoma
#894Angiogenesis Pathway Gene Polymorphisms for Therapy Selection
#895Genetic Variants Contributing to Risk of Prostate Cancer
#896Susceptibility locus for schizophrenia
#897Genetic variants on chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
#898Compositions and methods for diagnosing and treating macular degeneration
#899System and Method for Determining the Health of a Subject Using Polymorphic Risk Markers
#900Targets for use in diagnosis, prognosis and therapy of cancer